Genetic Polymorphisms in the Fibrinolytic System of Placentas with Massive Perivillous Fibrin Deposition

Placenta

Volumn 31, Issue 6, 2010, Pages 499-505

  Uxa, R ^a   Baczyk, D ^a   Kingdom, J C P ^a   Viero, S ^a   Casper, R ^a   Keating, S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Genetic polymorphisms; Intra uterine growth restriction; Massive perivillous fibrin deposition

Indexed keywords

DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOLYSIS; GENE LOCUS; GENETIC POLYMORPHISM; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MASSIVE PERIVILLOUS FIBRIN DEPOSITION; MATERNAL FLOOR INFARCTION; MEDICAL RECORD REVIEW; PERINATAL DEATH; PLACENTA DISORDER; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

CARBOXYPEPTIDASE U; CASE-CONTROL STUDIES; CHORIONIC VILLI; FEMALE; FIBRIN; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; PLACENTA DISEASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77953125414     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.03.013     Document Type: Article

References (41)

1. Katzman P.J., and Genest D.R. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 5 (2002) 159-164
2. Sebire N.J., Backos M., Goldin R.D., and Regan L. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 109 (2002) 570-573
3. Frank H.G., Malekzadeh F., Kertschanska S., et al. Immunohistochemistry of two different types of placental fibrinoid. Acta Anat (Basel) 150 (1994) 55-68
4. Vernof K.K., Benirschke K., Kephart G.M., Wasmoen T.L., and Gleich G.J. Maternal floor infarction: relationship to X cells, major basic protein, and adverse perinatal outcome. Am J Obstet Gynecol 167 (1992) 1355-1363
5. Redline R.W., Jiang J.G., and Shah D. Discordancy for maternal floor infarction in dizygotic twin placentas. Hum Pathol 34 (2003) 822-824
6. Bane A.L., and Gillan J.E. Massive perivillous fibrinoid causing recurrent placental failure. BJOG 110 (2003) 292-295
7. Naeye R.L. Maternal floor infarction. Hum Pathol 16 (1985) 823-828
8. Bedaiwy M.A., Falcone T., Mascha E.J., and Casper R.F. Genetic polymorphism in the fibrinolytic system and endometriosis. Obstet Gynecol 108 (2006) 162-168
9. Zorio E., Gilabert-Estelles J., Espana F., Ramon L.A., Cosin R., and Estelles A. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 15 (2008) 923-929
10. Dimova E.Y., and Kietzmann T. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost 100 (2008) 992-1006
11. Lang I.M., Moser K.M., and Schleef R.R. Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism. Arterioscler Thromb Vasc Biol 18 (1998) 808-815
12. Franco R.F., Fagundes M.G., Meijers J.C., et al. Identification of polymorphisms in the 5′-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis. Haematologica 86 (2001) 510-517
13. Viero S., Chaddha V., Alkazaleh F., et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 25 (2004) 735-741
14. Alkazaleh F., Chaddha V., Viero S., et al. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin. Am J Obstet Gynecol 194 (2006) 821-827
15. Toal M., Chaddha V., Windrim R., and Kingdom J. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin. J Obstet Gynaecol Can 30 (2008) 198-206
16. Toal M., Chan C., Fallah S., et al. Usefulness of a placental profile in high-risk pregnancies. Am J Obstet Gynecol 196 363 (2007) e361-e367
17. Toal M., Keating S., Machin G., et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol 198 330 (2008) e331-e337
18. Albaiges G., Missfelder-Lobos H., Lees C., Parra M., and Nicolaides K.H. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 96 (2000) 559-564
19. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 99 (2002) 159-167
20. Ross P., Hall L., Smirnov I., and Haff L. High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 16 (1998) 1347-1351
21. Benirschke K., and Driscoll S.G. The pathology of the human placenta (1967), Springer-Verlag, Berlin, New York
22. Fox H., and Elston C.W. Pathology of the placenta. Major Probl Pathol 7 (1978) 1-491
23. Bendon R.W., and Hommel A.B. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med 16 (1996) 293-297
24. Robb J.A., Benirschke K., Mannino F., and Voland J. Intrauterine latent herpes simplex virus infection: II. Latent neonatal infection. Hum Pathol 17 (1986) 1210-1217
25. Al-Adnani M., Kiho L., and Scheimberg I. Recurrent placental massive perivillous fibrin deposition associated with polymyositis: a case report and review of the literature. Pediatr Dev Pathol 11 (2008) 226-229
26. Sedano S., Gaffney G., Mortimer G., et al. Activated protein C resistance (APCR) and placental fibrin deposition. Placenta 29 (2008) 833-837
27. Redline R.W. Thrombophilia and placental pathology. Clin Obstet Gynecol 49 (2006) 885-894
28. Redline R.W., Boyd T., Campbell V., et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 7 (2004) 237-249
29. Svensson A.M., Waters B.L., Laszik Z.G., et al. The protein C system in placental massive perivillous fibrin deposition. Blood Coagul Fibrinolysis 15 (2004) 491-495
30. Dawson S., Hamsten A., Wiman B., Henney A., and Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 11 (1991) 183-190
31. Estelles A., Gilabert J., Grancha S., et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 79 (1998) 500-508
32. Gao M., Nakabayashi M., Sakura M., and Takeda Y. The imbalance of plasminogen activators and inhibitor in preeclampsia. J Obstet Gynaecol Res 22 (1996) 9-16
33. Mandsager N.T., Bendon R., Mostello D., Rosenn B., Miodovnik M., and Siddiqi T.A. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol 83 (1994) 750-754
34. Eichinger S. D-dimer testing in pregnancy. Pathophysiol Haemost Thromb 33 (2003) 327-329
35. Matern D., Schehata B.M., Shekhawa P., Strauss A.W., Bennett M.J., and Rinaldo P. Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab 72 (2001) 265-268
36. Gogia N., and Machin G.A. Maternal thrombophilias are associated with specific placental lesions. Pediatr Dev Pathol 11 (2008) 424-429
37. Gris J.-C. Trophoblast cells sense maternal hemostasis. Blood 107 (2006) 3019-3020
38. Carruth A, Strauss A, Bennett M, Narayan S, Ernst LM. Mutations in long-chain-3-hydroxyacyl-CoA dehydrogenase and placental maternal floor infarct/massive perivillous fibrin deposition. Pediatr Dev Pathol 2010;13.
39. Kraus F.T., Redline R.W., Gersell D.J., Nelson D.M., and Dicke J.M. Placental pathology (2004), American Registry of Pathology, Washington DC p. 284-8; 312-4
40. Birth weight for Gestational Age. Canadian perinatal surveillance system, health Canada. accessed at:. http://www.phac-aspc.gc.ca/rhs-ssg/bwga-pnag/index-eng.php
41. Fox G.E., Van Wesep R., Resau J.H., and Sun C.C. The effect of immersion formaldehyde fixation on human placental weight. Arch Pathol Lab Med 115 7 (1991 Jul) 726-728